EGFR and non-small cell lung carcinoma: Thus, amongst EGFRmut+ NSCLC patients at our centre, the risk of post-PD death may be accelerated or slowed down by the combined effects of smoking history and type of EGFR mutation, with the possibility of a synergistic relationship.